The India syndromic multiplex diagnostics market was valued at USD 89.09 million in 2025, expanding at a CAGR of 5.95% during the forecast period from 2026 to 2035. The driving factor for the market is the rising global prevalence and burden of infectious diseases, like respiratory infections, gastrointestinal illnesses, and sexually transmitted infections (STIs). Our healthcare research analyst, Deepa Pandey, analysed this value. She researched material types, clinical applications, regional growth drivers, and competitive landscapes. Her research is useful for medical product producers, healthcare providers, biotechnology firms, and even investors for competitive benchmarking and strategic decision-making.
